Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community

Authors: Zaimin Wang, Wendy E Hoy, Zhiqiang Wang

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Albuminuria marks renal disease and cardiovascular risk. It was estimated to contribute 75% of the risk of all-cause natural death in one Aboriginal group. The urine albumin/creatinine ratio (ACR) is commonly used as an index of albuminuria. This study aims to examine the associations between demographic factors, anthropometric index, blood pressure, lipid-protein measurements and other biomarkers and albuminuria in a cross-sectional study in a high-risk Australian Aboriginal population. The models will be evaluated for albuminuria at or above the microalbuminuria threshold, and at or above the “overt albuminuria” threshold with the potential to distinguish associations they have in common and those that differ.

Methods

This was a cross-sectional study of 598 adults aged 18–76 years. All participants were grouped into quartiles by age. Logistic regression models were used to explore the correlates of ACR categories.

Results

The significant correlates were systolic blood pressure (SBP), C-reactive protein (CRP), uric acid, diabetes, gamma-glutamyl transferase (GGT) (marginally significant, p = 0.054) and serum albumin (negative association) for ACR 17+ (mg/g) for men and 25+ for women. Independent correlates were SBP, uric acid, diabetes, total cholesterol, alanine amino transferase (ALT), Cystatin C and serum albumin (negative association) for overt albuminuria; and SBP, CRP and serum albumin only for microalbuminuria.

Conclusions

This is the most detailed modelling of pathologic albuminuria in this setting to date. The somewhat variable association with risk factors suggests that microalbuminuria and overt albuminuria might reflect different as well as shared phenomena.
Appendix
Available only for authorised users
Literature
1.
go back to reference Spencer J, Silva D, Hoy W: An epidemic of renal failure among Australian aboriginal. Med J Aust. 1998, 168: 537-541.PubMed Spencer J, Silva D, Hoy W: An epidemic of renal failure among Australian aboriginal. Med J Aust. 1998, 168: 537-541.PubMed
2.
go back to reference Cunningham J, Condon JR: Premature mortality in aboriginal adults in the Northern Territory. Med J Aust. 1996, 165: 309-312.PubMed Cunningham J, Condon JR: Premature mortality in aboriginal adults in the Northern Territory. Med J Aust. 1996, 165: 309-312.PubMed
3.
go back to reference Veroni M, Gracey M, Rouse I: Patterns of mortality in Western Australian aboriginals, 1983–89. Int J Epidemiol. 1994, 23: 73-81. 10.1093/ije/23.1.73.CrossRefPubMed Veroni M, Gracey M, Rouse I: Patterns of mortality in Western Australian aboriginals, 1983–89. Int J Epidemiol. 1994, 23: 73-81. 10.1093/ije/23.1.73.CrossRefPubMed
4.
go back to reference Cass A, Cunningham J, Wang Z, Hoy W: Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust. 2001, 175: 24-27.PubMed Cass A, Cunningham J, Wang Z, Hoy W: Regional variation in the incidence of end-stage renal disease in Indigenous Australians. Med J Aust. 2001, 175: 24-27.PubMed
5.
go back to reference Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-independent diabetic subjects. Nephrol Dial Transplant. 1997, 12: 2612-2617. 10.1093/ndt/12.12.2612.CrossRefPubMed Wirta O, Pasternack A, Mustonen J, Laippala P: Renal and cardiovascular predictors of 9-year total and sudden cardiac mortality in non-insulin-independent diabetic subjects. Nephrol Dial Transplant. 1997, 12: 2612-2617. 10.1093/ndt/12.12.2612.CrossRefPubMed
6.
go back to reference Hoy WE, Wang Z, Baker PRA, Kelly AM: Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian aboriginal community. Kidney Int. 2003, 63 (Suppl 83): S66-S73.CrossRef Hoy WE, Wang Z, Baker PRA, Kelly AM: Reduction in natural death and renal failure from a systematic screening and treatment program in an Australian aboriginal community. Kidney Int. 2003, 63 (Suppl 83): S66-S73.CrossRef
7.
go back to reference Hoy W, McDonald SP: Albuminuria: marker or target in Indigenous populations. Kidney Int. 2004, 66 (Suppl 92): S25-S31.CrossRef Hoy W, McDonald SP: Albuminuria: marker or target in Indigenous populations. Kidney Int. 2004, 66 (Suppl 92): S25-S31.CrossRef
8.
go back to reference Hoy WE: Renal disease in aboriginal Australians. Med J Aust. 1996, 165: 126-127.PubMed Hoy WE: Renal disease in aboriginal Australians. Med J Aust. 1996, 165: 126-127.PubMed
9.
go back to reference Wang Z, Hoy WE: The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community. Clin Kidney J. 2012, 5: 519-525. 10.1093/ckj/sfs125.CrossRefPubMedPubMedCentral Wang Z, Hoy WE: The predictive value of albuminuria for renal and nonrenal natural deaths over 14 years follow-up in a remote aboriginal community. Clin Kidney J. 2012, 5: 519-525. 10.1093/ckj/sfs125.CrossRefPubMedPubMedCentral
10.
go back to reference McDonald SP, Wang Z, Hoy WE: Physical and biochemical predictors of death in an Australian aboriginal cohort. Clin Expl Pharmacol P. 1999, 26: 618-621. 10.1046/j.1440-1681.1999.03104.x.CrossRef McDonald SP, Wang Z, Hoy WE: Physical and biochemical predictors of death in an Australian aboriginal cohort. Clin Expl Pharmacol P. 1999, 26: 618-621. 10.1046/j.1440-1681.1999.03104.x.CrossRef
11.
go back to reference Wang Z, Hoy W, Nicol JL, Su Q, Atkins R, Polkinghome KR: Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high –risk aboriginal population. Am J Kidney Dis. 2008, 52: 672-682. 10.1053/j.ajkd.2008.03.007.CrossRefPubMed Wang Z, Hoy W, Nicol JL, Su Q, Atkins R, Polkinghome KR: Predictive value of nephelometric and high-performance liquid chromatography assays of urine albumin for mortality in a high –risk aboriginal population. Am J Kidney Dis. 2008, 52: 672-682. 10.1053/j.ajkd.2008.03.007.CrossRefPubMed
12.
go back to reference Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996, 7: 930-937.PubMed Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on the prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol. 1996, 7: 930-937.PubMed
13.
go back to reference Rowley KG, Iser DM, Best J, O’Dea K, Leonard D, McDermitt R: Albuminuria in Australian aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia. 2000, 43: 1397-1403. 10.1007/s001250051545.CrossRefPubMed Rowley KG, Iser DM, Best J, O’Dea K, Leonard D, McDermitt R: Albuminuria in Australian aboriginal people: prevalence and associations with components of the metabolic syndrome. Diabetologia. 2000, 43: 1397-1403. 10.1007/s001250051545.CrossRefPubMed
14.
go back to reference Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA: Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn study. Diabetologia. 1998, 41: 694-700. 10.1007/s001250050970.CrossRefPubMed Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CDA: Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn study. Diabetologia. 1998, 41: 694-700. 10.1007/s001250050970.CrossRefPubMed
15.
go back to reference Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM: Risk factors for kidney damage in the adult population of Wadena, Minnesota. Am J Epidemiol. 1997, 145: 91-102. 10.1093/oxfordjournals.aje.a009091.CrossRefPubMed Goetz FC, Jacobs DR, Chavers B, Roel J, Yelle M, Sprafka JM: Risk factors for kidney damage in the adult population of Wadena, Minnesota. Am J Epidemiol. 1997, 145: 91-102. 10.1093/oxfordjournals.aje.a009091.CrossRefPubMed
16.
go back to reference Smulders YM, Rakic M, Stehouwer CDA, Weijers RN, Slaats EH, Silberbusch J: Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care. 1997, 20: 999-1005. 10.2337/diacare.20.6.999.CrossRefPubMed Smulders YM, Rakic M, Stehouwer CDA, Weijers RN, Slaats EH, Silberbusch J: Determinants of progression of microalbuminuria in patients with NIDDM. Diabetes Care. 1997, 20: 999-1005. 10.2337/diacare.20.6.999.CrossRefPubMed
18.
go back to reference Glassock RJ: Prevention of microalbuminuria in type-2 diabetes: millimetres or milligrams. J am Soc Nephrol. 2006, 17: 3276-3278. 10.1681/ASN.2006101131.CrossRefPubMed Glassock RJ: Prevention of microalbuminuria in type-2 diabetes: millimetres or milligrams. J am Soc Nephrol. 2006, 17: 3276-3278. 10.1681/ASN.2006101131.CrossRefPubMed
19.
go back to reference Hodge AM, Dowse GK, Zimmet PZ: Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med. 1996, 13: 441-449. 10.1002/(SICI)1096-9136(199605)13:5<441::AID-DIA99>3.0.CO;2-J.CrossRefPubMed Hodge AM, Dowse GK, Zimmet PZ: Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med. 1996, 13: 441-449. 10.1002/(SICI)1096-9136(199605)13:5<441::AID-DIA99>3.0.CO;2-J.CrossRefPubMed
20.
go back to reference Konen JC, Summerson JH, Bell RA, Curtis LG: Racial differences in symptoms and complications in adults with type-2 diabetes mellitus. Ethn Health. 1999, 4: 39-49. 10.1080/13557859998182.CrossRefPubMed Konen JC, Summerson JH, Bell RA, Curtis LG: Racial differences in symptoms and complications in adults with type-2 diabetes mellitus. Ethn Health. 1999, 4: 39-49. 10.1080/13557859998182.CrossRefPubMed
21.
go back to reference Guo X, Cui J, Wagenknecht LE, Norris JM, Haffner SM, Darwin C, Jinagouda S, Rotter JI, Saad MF: Cosegragation of albuminuria and blood pressure: the InsulinResistance Atherosclerosis (IRAS) family study. Am J Hypertens. 2005, 18: 823-827. 10.1016/j.amjhyper.2005.01.022.CrossRefPubMed Guo X, Cui J, Wagenknecht LE, Norris JM, Haffner SM, Darwin C, Jinagouda S, Rotter JI, Saad MF: Cosegragation of albuminuria and blood pressure: the InsulinResistance Atherosclerosis (IRAS) family study. Am J Hypertens. 2005, 18: 823-827. 10.1016/j.amjhyper.2005.01.022.CrossRefPubMed
22.
go back to reference Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PWM, Li RK, Mickle DAG, Verma S: C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation. 2004, 109: 833-836. 10.1161/01.CIR.0000117087.27524.0E.CrossRefPubMed Li SH, Szmitko PE, Weisel RD, Wang CH, Fedak PWM, Li RK, Mickle DAG, Verma S: C-reactive protein upregulates complement-inhibitory factors in endothelial cells. Circulation. 2004, 109: 833-836. 10.1161/01.CIR.0000117087.27524.0E.CrossRefPubMed
23.
go back to reference Albert MA, Glynn RJ, Buring J, Ridker PM: C-reactive protein levels among women of various ethnic groups living in the United Status (from the Women’s Health Study). Am J Cardiol. 2004, 93: 1238-1242. 10.1016/j.amjcard.2004.01.067.CrossRefPubMed Albert MA, Glynn RJ, Buring J, Ridker PM: C-reactive protein levels among women of various ethnic groups living in the United Status (from the Women’s Health Study). Am J Cardiol. 2004, 93: 1238-1242. 10.1016/j.amjcard.2004.01.067.CrossRefPubMed
24.
go back to reference Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV: Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation. 2004, 109: 3022-3028. 10.1161/01.CIR.0000130640.77501.79.CrossRefPubMed Greenfield JR, Samaras K, Jenkins AB, Kelly PJ, Spector TD, Gallimore JR, Pepys MB, Campbell LV: Obesity is an important determinant of baseline serum C-reactive protein concentration in monozygotic twins, independent of genetic influences. Circulation. 2004, 109: 3022-3028. 10.1161/01.CIR.0000130640.77501.79.CrossRefPubMed
25.
go back to reference Chien KL, Hsu HC, Chen MF, Lee YT: Association of C-reactive protein, smoking and metabolic syndrome among the health check-up population. Acta Cardio Sin. 2005, 21: 98-104. Chien KL, Hsu HC, Chen MF, Lee YT: Association of C-reactive protein, smoking and metabolic syndrome among the health check-up population. Acta Cardio Sin. 2005, 21: 98-104.
26.
go back to reference Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A: Association between serum c-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Internal Med. 2004, 43: 919-925. 10.2169/internalmedicine.43.919.CrossRef Nakamura M, Onoda T, Itai K, Ohsawa M, Satou K, Sakai T, Segawa T, Sasaki J, Tonari Y, Hiramori K, Okayama A: Association between serum c-reactive protein levels and microalbuminuria: a population-based cross-sectional study in northern Iwate, Japan. Internal Med. 2004, 43: 919-925. 10.2169/internalmedicine.43.919.CrossRef
27.
go back to reference Wang Z, Hoy WE: C- reactive protein and the risk of developing type 2 diabetes in aboriginal Australians. Diabetes Res Clin Pr. 2007, 76: 37-43. 10.1016/j.diabres.2006.07.018.CrossRef Wang Z, Hoy WE: C- reactive protein and the risk of developing type 2 diabetes in aboriginal Australians. Diabetes Res Clin Pr. 2007, 76: 37-43. 10.1016/j.diabres.2006.07.018.CrossRef
28.
go back to reference Festa A, D’agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int. 2000, 58: 1703-1710. 10.1046/j.1523-1755.2000.00331.x.CrossRefPubMed Festa A, D’agostino R, Howard G, Mykkanen L, Tracy RP, Haffner SM: Inflammation and microalbuminuria in nondiabetic and type 2 diabetic subjects: the insulin resistance atherosclerosis study. Kidney Int. 2000, 58: 1703-1710. 10.1046/j.1523-1755.2000.00331.x.CrossRefPubMed
29.
go back to reference Stuveling EM, Bakker SJL, Hillege HL, Burgeruhof JGM, Jone PED, Gans ROB, De ZD: C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension. 2004, 43: 791-796. 10.1161/01.HYP.0000120125.08867.42.CrossRefPubMed Stuveling EM, Bakker SJL, Hillege HL, Burgeruhof JGM, Jone PED, Gans ROB, De ZD: C-reactive protein modifies the relationship between blood pressure and microalbuminuria. Hypertension. 2004, 43: 791-796. 10.1161/01.HYP.0000120125.08867.42.CrossRefPubMed
30.
go back to reference Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademstriou V, Toutouzas P, Stefanadis C, Kallikazaros I: Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardio. 2005, 96: 946-951. 10.1016/j.amjcard.2005.05.052.CrossRef Tsioufis C, Dimitriadis K, Chatzis D, Vasiliadou C, Tousoulis D, Papademstriou V, Toutouzas P, Stefanadis C, Kallikazaros I: Relation of microalbuminuria to adiponectin and augmented C-reactive protein levels in men with essential hypertension. Am J Cardio. 2005, 96: 946-951. 10.1016/j.amjcard.2005.05.052.CrossRef
31.
go back to reference Jousilahti P, Rastenyte D, Tuomilehto J: Serum gamma-glutamyl transferase, self-reported alcohol drinking and the risk of stroke. Stroke. 2000, 31: 1851-1855. 10.1161/01.STR.31.8.1851.CrossRefPubMed Jousilahti P, Rastenyte D, Tuomilehto J: Serum gamma-glutamyl transferase, self-reported alcohol drinking and the risk of stroke. Stroke. 2000, 31: 1851-1855. 10.1161/01.STR.31.8.1851.CrossRefPubMed
32.
go back to reference Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28, 838 middle-aged men and women. Eur Heart J. 2006, 27: 2170-2176. 10.1093/eurheartj/ehl086.CrossRefPubMed Lee DH, Silventoinen K, Hu G, Jacobs DR, Jousilahti P, Sundvall J, Tuomilehto J: Serum gamma-glutamyltransferase predicts non-fatal myocardial infarction and fatal coronary heart disease among 28, 838 middle-aged men and women. Eur Heart J. 2006, 27: 2170-2176. 10.1093/eurheartj/ehl086.CrossRefPubMed
33.
go back to reference Meisinger C, Lowel H, Heier M, Schneider A, Thorand B: Serum gamma- glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med. 2005, 258: 527-535. 10.1111/j.1365-2796.2005.01572.x.CrossRefPubMed Meisinger C, Lowel H, Heier M, Schneider A, Thorand B: Serum gamma- glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population. J Intern Med. 2005, 258: 527-535. 10.1111/j.1365-2796.2005.01572.x.CrossRefPubMed
34.
go back to reference Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem. 2003, 49: 1358-1366. 10.1373/49.8.1358.CrossRefPubMed Lee DH, Jacobs DR, Gross M, Kiefe CI, Roseman J, Lewis CE, Steffes M: Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the coronary artery risk development in young adults (CARDIA) study. Clin Chem. 2003, 49: 1358-1366. 10.1373/49.8.1358.CrossRefPubMed
35.
go back to reference Lee DH, Jacobs DR, Gross M, Steffes M: Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the coronary artery risk sevelopment in young adults (CARDIA) study. Clin Chem. 2005, 51: 1185-1191. 10.1373/clinchem.2004.045872.CrossRefPubMed Lee DH, Jacobs DR, Gross M, Steffes M: Serum gamma-glutamyltransferase was differently associated with microalbuminuria by status of hypertension or diabetes: the coronary artery risk sevelopment in young adults (CARDIA) study. Clin Chem. 2005, 51: 1185-1191. 10.1373/clinchem.2004.045872.CrossRefPubMed
36.
go back to reference Hoy WE, Wang Z, VanBuynder P, Backer PRA, McDonald SM, Mathews JD: The natural history of renal disease in Australian aborigines: part 2 albuminuria predicts natural death and renal failure. Kidney Int. 2001, 60: 249-256. 10.1046/j.1523-1755.2001.00793.x.CrossRefPubMed Hoy WE, Wang Z, VanBuynder P, Backer PRA, McDonald SM, Mathews JD: The natural history of renal disease in Australian aborigines: part 2 albuminuria predicts natural death and renal failure. Kidney Int. 2001, 60: 249-256. 10.1046/j.1523-1755.2001.00793.x.CrossRefPubMed
37.
go back to reference Conlgrave KM, Saunders JB, Reznik RB, Whitfield JB: Prediction of alcohol-related ham by laboratory test results. Clin Chem. 1993, 39: 2266-2270. Conlgrave KM, Saunders JB, Reznik RB, Whitfield JB: Prediction of alcohol-related ham by laboratory test results. Clin Chem. 1993, 39: 2266-2270.
38.
go back to reference Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Havhurst BG, Rees M, Kile E, Walker KA, Wang Z: The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian aboriginal community. Kidney Int. 1998, 54: 1296-1304. 10.1046/j.1523-1755.1998.00099.x.CrossRefPubMed Hoy WE, Mathews JD, McCredie DA, Pugsley DJ, Havhurst BG, Rees M, Kile E, Walker KA, Wang Z: The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian aboriginal community. Kidney Int. 1998, 54: 1296-1304. 10.1046/j.1523-1755.1998.00099.x.CrossRefPubMed
39.
go back to reference Conigrave KM, Degenhardt LJ, Whitefield JB, Saunders JB, Helander A, Tabakoff B: CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res. 2002, 26: 332-339. 10.1111/j.1530-0277.2002.tb02542.x.CrossRefPubMed Conigrave KM, Degenhardt LJ, Whitefield JB, Saunders JB, Helander A, Tabakoff B: CDT, GGT, and AST as markers of alcohol use: the WHO/ISBRA collaborative project. Alcohol Clin Exp Res. 2002, 26: 332-339. 10.1111/j.1530-0277.2002.tb02542.x.CrossRefPubMed
40.
go back to reference Whitfield JB: Serum -glutamyltransferase and risk of disease. Clin Chem. 2007, 1: 1-2. Whitfield JB: Serum -glutamyltransferase and risk of disease. Clin Chem. 2007, 1: 1-2.
41.
go back to reference Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001, 38: 263-355. 10.1080/20014091084227.CrossRefPubMed Whitfield JB: Gamma glutamyl transferase. Crit Rev Clin Lab Sci. 2001, 38: 263-355. 10.1080/20014091084227.CrossRefPubMed
42.
go back to reference Lee DH, Blomhoff R, Jacobs DR: Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004, 38: 535-539. 10.1080/10715760410001694026.CrossRefPubMed Lee DH, Blomhoff R, Jacobs DR: Is serum gamma glutamyltransferase a marker of oxidative stress?. Free Radic Res. 2004, 38: 535-539. 10.1080/10715760410001694026.CrossRefPubMed
43.
go back to reference Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A: Gamma- glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med. 1997, 22: 853-860. 10.1016/S0891-5849(96)00422-4.CrossRefPubMed Paolicchi A, Tongiani R, Tonarelli P, Comporti M, Pompella A: Gamma- glutamyl transpeptidase-dependent lipid peroxidation in isolated hepatocytes and HepG2 hepatoma cells. Free Radic Biol Med. 1997, 22: 853-860. 10.1016/S0891-5849(96)00422-4.CrossRefPubMed
44.
go back to reference Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M: Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med. 1998, 25: 786-792. 10.1016/S0891-5849(98)00127-0.CrossRefPubMed Drozdz R, Parmentier C, Hachad H, Leroy P, Siest G, Wellman M: Glutamyltransferase dependent generation of reactive oxygen species from a glutathione/transferrin system. Free Radic Biol Med. 1998, 25: 786-792. 10.1016/S0891-5849(98)00127-0.CrossRefPubMed
45.
go back to reference Bathum L, Petersen HC, Rosholm JU, Hyltoft PP, Vaupel J, Christensen K: Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001, 47: 81-87.PubMed Bathum L, Petersen HC, Rosholm JU, Hyltoft PP, Vaupel J, Christensen K: Evidence for a substantial genetic influence on biochemical liver function tests: results from a population-based Danish twin study. Clin Chem. 2001, 47: 81-87.PubMed
46.
go back to reference Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG: Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem. 2002, 48: 1426-1431.PubMed Whitfield JB, Zhu G, Nestler JE, Heath AC, Martin NG: Genetic covariation between serum gamma-glutamyltransferase activity and cardiovascular risk factors. Clin Chem. 2002, 48: 1426-1431.PubMed
47.
go back to reference Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011, 305: 1553-1559. 10.1001/jama.2011.451.CrossRefPubMed Tangri N, Stevens LA, Griffith J, Tighiouart H, Djurdjev O, Naimark D, Levin A, Levey AS: A predictive model for progression of chronic kidney disease to kidney failure. JAMA. 2011, 305: 1553-1559. 10.1001/jama.2011.451.CrossRefPubMed
48.
go back to reference Huo L, Xu M, Li R, Dai M, Wang JG, Ning G, Li XY: Prevalence and prevalence of microalbuminuria in persons with various glucose tolerance levels. ZhongHua YiXue Za Zhi. 2007, 87: 2537-2540. Huo L, Xu M, Li R, Dai M, Wang JG, Ning G, Li XY: Prevalence and prevalence of microalbuminuria in persons with various glucose tolerance levels. ZhongHua YiXue Za Zhi. 2007, 87: 2537-2540.
49.
go back to reference Anvari MS, Boroumand MA, Pourgholi L, Sheikhfathollahi M, Rouhzendeh M, Rabbani S, Goodarzynejad H: Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res. 2009, 40: 399-405. 10.1016/j.arcmed.2009.06.011.CrossRefPubMed Anvari MS, Boroumand MA, Pourgholi L, Sheikhfathollahi M, Rouhzendeh M, Rabbani S, Goodarzynejad H: Potential link of microalbuminuria with metabolic syndrome in patients undergoing coronary angiography. Arch Med Res. 2009, 40: 399-405. 10.1016/j.arcmed.2009.06.011.CrossRefPubMed
50.
go back to reference Agrawal V, Vanhecke TE, Rai B, Franklin BA, Sangal RB, McCullough PA: Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Prac. 2009, 113: c140-c147. 10.1159/000232594.CrossRef Agrawal V, Vanhecke TE, Rai B, Franklin BA, Sangal RB, McCullough PA: Albuminuria and renal function in obese adults evaluated for obstructive sleep apnea. Nephron Clin Prac. 2009, 113: c140-c147. 10.1159/000232594.CrossRef
51.
go back to reference Prasad GV, Bandukwala F, Huang M, Zaltman JS: Microalbuminuria post-renal transplantation: relation to cardiovascular risk factors and C-reactive protein. Clin Transplant. 2009, 23: 313-320. 10.1111/j.1399-0012.2008.00913.x.CrossRefPubMed Prasad GV, Bandukwala F, Huang M, Zaltman JS: Microalbuminuria post-renal transplantation: relation to cardiovascular risk factors and C-reactive protein. Clin Transplant. 2009, 23: 313-320. 10.1111/j.1399-0012.2008.00913.x.CrossRefPubMed
Metadata
Title
The correlates of urinary albumin to creatinine ratio (ACR) in a high risk Australian aboriginal community
Authors
Zaimin Wang
Wendy E Hoy
Zhiqiang Wang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-176

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.